|
|
Article: Normalizing hemoglobin aids hemodialysis patients.
- Article from:
- Drug Week
- Article date:
- July 9, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JUL 9 - (NewsRx.com & NewsRx.net) -- Normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin.
"Partial correction of anemia by erythropoietin improves hemodialysis (HD)-associated immunosuppression. It is not known whether hemoglobin normalization improves immune status further. The authors prospectively compared the immune function of HD patients with congestive heart failure or ischemic heart disease on erythropoietin therapy randomized to normal versus anemic blood hemoglobin concentration," researchers in the United States report.
"HD patients were randomized into a normal hemoglobin group ...